explore -WSS

explore

author：leisure time 2025-09-27 12:21:50 - browse：864

An army of wooden figures under blue and pink lighting — biotech coverage from STAT — Adobe

Biotech startup ReNAgade Therapeutics is cutting staff just seven months after raising the largest Series A round in the industry this year.

ReNAgade launched in May with hopes of becoming a one-stop shop for medicines targeting RNA, the genetic blueprints that cells use to make proteins instrumental in numerous diseases. These types of medicines are in high demand following the advent of mRNA vaccines for Covid and RNA-silencing therapies made by companies like Alnylam Pharmaceuticals.

ReNAgade was able to capitalize on that excitement when it raised a $300 million Series A round led by MPM Capital’s BioImpact Capital and F2 Ventures. But in recent days, the company decided to lay off around 10% of its 100-person team, according to a company statement and former employees’ posts on social media.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

WSS

Melinda French Gates resigns from Gates Foundation

UnitedHealth sued over use of algorithm in Medicare Advantage plans

Publishing genetic code of viruses could cause disaster

Weight loss drugs should be covered by insurers, AMA says

CVS, Rite Aid closures threaten to worsen pharmacy deserts

Getting Alzheimer's drug Leqembi to patients can be a challenge

focus

explore

focus

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Cue Health's Covid

Medicare details structure of new drug price negotiation program

Bird flu outbreak in cows is latest avian flu curveball

New air purifier tech could be key to improving indoor air quality

FTC falls short on scrutinizing hospital mergers, study says

United colonoscopy coverage change 'may cost lives,' doctors say

Medical school prerequisites are outdated

Supreme Court strikes down use of affirmative action

Diversity in clinical trials starts with building trust, experts say

explore

Dogs on Prozac: What pet anti

FDA reorg will put new emphasis on investigations, sources say

UnitedHealth financials solid despite Change Healthcare cyberattack

Dogs on Prozac: What pet anti

Key Senate committee drafts bipartisan bill to stem drug shortages

Key Senate committee drafts bipartisan bill to stem drug shortages

hotspot

focus

entertainment

Wikipedia